Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Aeglea BioTherapeutics Inc (AGLE)
Aeglea BioTherapeutics Inc (AGLE) Financials

AGLE Aeglea BioTherapeutics Inc

12.01

0.00 (0.00%)

20 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-41.049	-44.236	-66.282	-97.257	-66.089	-48.464	-92.577	-164.062
Return on Equity (%)	-106.47	-48.076	-75.316	-122.743	-80.928	-58.81	-124.868	-289.167
Return on Invested Capital (%)	-107.649	-48.971	-77.395	-127.536	-82.895	-59.792	-130.079	-163.595
Operating Margin (%)	-468.842	-523.266	-1140.638	N/A	N/A	-350.392	-3604.594	-38241.084
Net Profit Margin (%)	-468.842	-523.266	-1140.638	N/A	N/A	-351.145	-3598.755	-38238.149
Book Value Per Share	2.81	1.963	2.036	1.579	2.456	1.439	0.714	20.624
Earnings Per Share	-0.968	-1.062	-1.339	-2.056	-1.421	-1.128	-1.189	-26.017
Cash Per Share	2.131	0.5	0.678	0.506	1.583	0.26	0.495	14.506
Working Capital Per Share	2.788	1.925	2.006	1.475	2.342	1.35	0.675	23.771
Operating Profit Per Share	0.207	0.203	0.117	N/A	N/A	0.321	0.033	0.068
EBIT Per Share	-0.968	-1.062	-1.339	-2.056	-1.421	-1.126	-1.191	-26.019
EBITDA Per Share	-0.968	-1.062	-1.339	-2.056	-1.421	-1.126	-1.191	-26.019
Free Cash Flow Per Share	-0.965	-1.048	-1.335	-2.028	-1.363	-1.145	-1.208	-26.074

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	13.43M	16.67M	24.14M	29.08M	47.96M	49.36M	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-9322.222	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	-9304.04	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	48.63M
Price to Earnings Ratio	-0.29
Price to Sales Ratio	109.19
Price to Cash Ratio	0.51
Price to Book Ratio	0.36
Dividend Yield	-

Share Statistics

Shares Outstanding	4.05M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Aeglea BioTherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions